DENTSPLY SIRONA Inc.

NasdaqGS:XRAY Voorraadrapport

Marktkapitalisatie: US$4.8b

DENTSPLY SIRONA Beheer

Beheer criteriumcontroles 2/4

De CEO DENTSPLY SIRONA is Simon Campion, benoemd in Sep2022, heeft een ambtstermijn van 2.17 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 8.52M, bestaande uit 11.7% salaris en 88.3% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.089% van de aandelen van het bedrijf, ter waarde $ 4.24M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 1.5 jaar en 4.7 jaar.

Belangrijke informatie

Simon Campion

Algemeen directeur

US$8.5m

Totale compensatie

Percentage CEO-salaris11.7%
Dienstverband CEO2.2yrs
Eigendom CEO0.09%
Management gemiddelde ambtstermijn1.5yrs
Gemiddelde ambtstermijn bestuur4.7yrs

Recente managementupdates

Recent updates

DENTSPLY SIRONA (NASDAQ:XRAY) Hasn't Managed To Accelerate Its Returns

Oct 13
DENTSPLY SIRONA (NASDAQ:XRAY) Hasn't Managed To Accelerate Its Returns

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive But Perhaps Not Attractive Enough

Sep 25
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive But Perhaps Not Attractive Enough

Is It Time To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Sep 05
Is It Time To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Is There An Opportunity With DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) 21% Undervaluation?

Aug 18
Is There An Opportunity With DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) 21% Undervaluation?

Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Have Hit The Brakes

Jul 11
Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Have Hit The Brakes

A Tough Macro Environment Makes Dentsply Sirona's Turnaround Even Harder

Jul 02

Insufficient Growth At DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Hampers Share Price

Jun 11
Insufficient Growth At DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Hampers Share Price

We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt

May 24
We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt

Dentsply Sirona: I'm Buying The Pullback In This Medtech Leader

Apr 24

Are Investors Undervaluing DENTSPLY SIRONA Inc. (NASDAQ:XRAY) By 47%?

Apr 22
Are Investors Undervaluing DENTSPLY SIRONA Inc. (NASDAQ:XRAY) By 47%?

There's No Escaping DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Muted Revenues

Mar 10
There's No Escaping DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Muted Revenues

Here's Why DENTSPLY SIRONA (NASDAQ:XRAY) Has A Meaningful Debt Burden

Feb 16
Here's Why DENTSPLY SIRONA (NASDAQ:XRAY) Has A Meaningful Debt Burden

DENTSPLY SIRONA (NASDAQ:XRAY) Has More To Do To Multiply In Value Going Forward

Jan 29
DENTSPLY SIRONA (NASDAQ:XRAY) Has More To Do To Multiply In Value Going Forward

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Could Be 28% Below Their Intrinsic Value Estimate

Jan 11
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Could Be 28% Below Their Intrinsic Value Estimate

Is It Too Late To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Nov 25
Is It Too Late To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

These 4 Measures Indicate That DENTSPLY SIRONA (NASDAQ:XRAY) Is Using Debt Extensively

Nov 06
These 4 Measures Indicate That DENTSPLY SIRONA (NASDAQ:XRAY) Is Using Debt Extensively

Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Paint A Concerning Picture

Oct 15
Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Paint A Concerning Picture

An Intrinsic Calculation For DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Suggests It's 46% Undervalued

Sep 18
An Intrinsic Calculation For DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Suggests It's 46% Undervalued

DENTSPLY SIRONA (NASDAQ:XRAY) Has A Pretty Healthy Balance Sheet

Jul 31
DENTSPLY SIRONA (NASDAQ:XRAY) Has A Pretty Healthy Balance Sheet

The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

Jul 09
The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

A Look At The Fair Value Of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Jun 20
A Look At The Fair Value Of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

When Should You Buy DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Jun 02
When Should You Buy DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Investors Don't See Light At End Of DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Tunnel

May 15
Investors Don't See Light At End Of DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Tunnel

The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

Apr 05
The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

Is DENTSPLY SIRONA (NASDAQ:XRAY) Using Too Much Debt?

Mar 07
Is DENTSPLY SIRONA (NASDAQ:XRAY) Using Too Much Debt?

We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt

Nov 09
We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt

Dentsply Sirona names Glenn Coleman as new CFO

Sep 22

Dentsply Sirona hires Simon Campion as president, CEO

Aug 25

Dentsply Sirona receives noncompliance notice from Nasdaq

Aug 16

Dentsply Sirona: Weakening Fundamentals Outweigh 'Defensives' Argument

Jul 18

Analyse CEO-vergoeding

Hoe is Simon Campion's beloning veranderd ten opzichte van DENTSPLY SIRONA's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

-US$185m

Mar 31 2024n/an/a

-US$95m

Dec 31 2023US$9mUS$1m

-US$132m

Sep 30 2023n/an/a

-US$214m

Jun 30 2023n/an/a

-US$1b

Mar 31 2023n/an/a

-US$1b

Dec 31 2022US$8mUS$304k

-US$950m

Compensatie versus markt: De totale vergoeding ($USD 8.52M ) Simon } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 6.65M ).

Compensatie versus inkomsten: De vergoeding van Simon is gestegen terwijl het bedrijf verliesgevend is.

CEO

Simon Campion (52 yo)

2.2yrs

Tenure

US$8,518,987

Compensatie

Mr. Simon D. Campion serves as Chief Executive Officer at DENTSPLY SIRONA Inc. since September 12, 2022 and also serves as its President & Director since September 2022. He served as an Executive Vice Pres...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Simon Campion
CEO, President & Director2.2yrsUS$8.52m0.089%
$ 4.2m
Glenn Coleman
Executive VP & CFO2.2yrsUS$3.90m0.013%
$ 605.2k
Richard Rosenzweig
Executive VP of Corporate Development1.8yrsUS$4.35m0.0052%
$ 248.6k
Robert Johnson
Senior VP & Chief Supply Chain Officer and Head of Sustainabilityless than a yearUS$2.94m0.010%
$ 481.9k
Kevin Boyle
Senior VP & Chief Technology Officerless than a yeargeen gegevensgeen gegevens
Andrea Daley
Vice President of Investor Relationsno datageen gegevensgeen gegevens
Andrea Frohning
Senior VP & Chief Human Resources Officer1.3yrsgeen gegevens0.00090%
$ 42.9k
Emily Miner
Senior VP of Global Quality and Regulatory & Chief Quality Officer1.5yrsgeen gegevensgeen gegevens
Dan Workinger
Treasurerno datageen gegevensgeen gegevens
Dane Baumgardner
Attorney-In-Factno datageen gegevensgeen gegevens
Gerard Campbell
Group Vice President for EMEA RCOno datageen gegevensgeen gegevens
Bruce Peatey
Group Vice President for APAC RCOno datageen gegevensgeen gegevens

1.5yrs

Gemiddelde duur

55yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van XRAY wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.5 jaar), wat duidt op een nieuw team.

Bestuursleden

NaamPositieTenureCompensatieEigendom
Simon Campion
CEO, President & Director2.2yrsUS$8.52m0.089%
$ 4.2m
Clyde Hosein
Independent Director4.2yrsUS$300.00k0.0090%
$ 429.5k
Betsy Holden
Independent Director6.8yrsUS$315.00k0.0013%
$ 63.8k
Leslie Varon
Independent Director6.8yrsUS$325.00k0.013%
$ 600.5k
Brian Gladden
Independent Directorless than a yearUS$25.00kgeen gegevens
Gregory Lucier
Independent Chairman5.5yrsUS$318.75k0.035%
$ 1.6m
William Deese
Independent Director13.8yrsUS$320.00k0.017%
$ 824.3k
Janet Vergis
Independent Director5.2yrsUS$315.00k0.011%
$ 513.3k
Ilse Wenzel
Independent Director2.8yrsUS$310.00k0.0041%
$ 197.1k
Jonathan Mazelsky
Independent Director1.5yrsUS$260.44k0.0027%
$ 129.5k

4.7yrs

Gemiddelde duur

61.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van XRAY wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.7 jaar).